Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jessica B. Bowman Bauldry"'
Autor:
Richard E. Royal, Anthony Lucci, Merrick I. Ross, Mandar Karhade, Joshua Upshaw, Sapna Pradyuman Patel, Jessica B. Bowman Bauldry, Carolyn S. Hall
Publikováno v:
Journal of the American College of Surgeons. 227:116-124
Background Management of stage IV melanoma patients remains a challenge. In spite of promising new therapies, many patients develop resistance and progression. The aim of this pilot study was to determine if circulating tumor cells (CTCs) are associa
Autor:
Isabella C. Glitza, Joshua Upshaw, Patrick Hwu, Richard E. Royal, Mandar Karhade, Michael A. Davies, Carolyn S. Hall, Merrick I. Ross, Jeffrey E. Lee, Hussein Abdul-Hassan Tawbi, Anthony Lucci, Rodabe N. Amaria, Jennifer A. Wargo, Michael K.K. Wong, Jessica B. Bowman Bauldry, Boomadevi Narendran, Sapna Pradyuman Patel, Adi Diab, Jeffrey E. Gershenwald
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 26(8)
Purpose: There is a need for sensitive, reproducible biomarkers for patients with stage III melanoma to guide clinical decision making. Circulating tumor cells (CTCs) can be detected in patients with melanoma; however, there are limited data regardin
Autor:
Lily M. Valad, Anthony Lucci, Henry Mark Kuerer, Mandar Karhade, Jessica B. Bowman Bauldry, Sarah M. DeSnyder, Carolyn S. Hall
Publikováno v:
Journal of the American College of Surgeons. 223:20-29
Circulating tumor cells (CTCs) can be identified in approximately 25% of nonmetastatic breast cancer patients, and data are emerging regarding their prognostic significance. We hypothesized that CTCs identified before resection of the primary tumor w
Autor:
Volkmar Mueller, M. Maestro, Denise M. Wolf, Justin Stebbing, Karsten Weber, Paul Blanche, Masakazu Toi, Antonio Llombart-Cussac, Alessandra Meddis, Andreas D. Hartkopf, Jun Horiguchi, Fabien Reyal, Randi R. Mathiesen, Olav Engebraaten, Charlotte Proudhon, Laura J. Esserman, Paul Cottu, Rafael Gisbert-Criado, José A. García-Sáenz, Patrice Viens, Koenraad d'Hollander, Sara Y. Brucker, François-Clément Bidard, Maria Rosa Cappelletti, Elin Borgen, John W. Park, Dominic Amara, Daisuke Takata, Klaus Pantel, Vicente Carañana, Jaco Kraan, Jessica B. Bowman Bauldry, Stefan Michiels, Noriyoshi Fujisawa, Eduardo Díaz-Rubio, Jose Vidal-Martinez, Hideaki Tokiniwa, Françoise Rothé, Bjørn Naume, Stefan Sleijfer, Anthony Lucci, Mandar Karhade, Aurélien Latouche, Michail Ignatiadis, Carolyn S. Hall, Sibylle Loibl, Florin-Andrei Taran, Daniele Generali, Jean-Yves Pierga, Sabine Riethdorf, Jeffrey B. Smerage, Wendy Onstenk, Rin Nagaoka, Laura Muinelo-Romay, Mark Jesus M. Magbanua
Publikováno v:
Journal of the National Cancer Institute, 110(6):djy018, 560-567. Oxford University Press
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
Consejo Superior de Investigaciones Científicas (CSIC)
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
Consejo Superior de Investigaciones Científicas (CSIC)
Background: We conducted a meta-analysis in nonmetastatic breast cancer patients treated by neoadjuvant chemotherapy (NCT) to assess the clinical validity of circulating tumor cell (CTC) detection as a prognostic marker. Methods: We collected individ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7081fc5de0490a8b10de50cb8818794e
https://pure.eur.nl/en/publications/34dfe697-929d-471e-9878-18ec73f848c6
https://pure.eur.nl/en/publications/34dfe697-929d-471e-9878-18ec73f848c6
Autor:
Oluwadamilola M. Fayanju, Anthony Lucci, Henry Mark Kuerer, Lily M. Valad, Carlos H. Barcenas, Jessica B. Bowman Bauldry, Sarah M. DeSnyder, Mandar Karhade, Carolyn S. Hall
Obesity (BMI≥30) may be an etiologic and prognostic factor in inflammatory breast cancer (IBC). We examined the relationship between BMI, pathologic complete response (pCR), and circulating-tumor-cell (CTC) levels in IBC.Cohort included IBC patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8e17d47d080c6d670e5388aa5e6b8eb
https://europepmc.org/articles/PMC5770232/
https://europepmc.org/articles/PMC5770232/
Autor:
Carolyn S. Hall, Christina L. Roland, Merrick I. Ross, Richard E. Royal, Mandar Karhade, Anthony Lucci, Barbara Laubacher, Joshua Upshaw, Jessica B. Bowman Bauldry
Publikováno v:
Journal of Clinical Oncology. 33:9016-9016
9016 Background: There is a need for more sensitive and specific prognostic markers for advanced stage melanoma patients to help improve the risk-benefit ratio of systemic adjuvant therapies. While...